Plaque psoriasis is more than just a skin condition—it’s a chronic, immune-mediated disorder that can deeply affect a person’s quality of life. That’s why it’s essential for healthcare professionals to develop effective patient education strategies that address safety concerns, improve communication, and encourage therapy adherence.

In this episode, we’re joined by Dr. Steven Feldman, a renowned Professor of Dermatology, Pathology, and Social Sciences & Health Policy at Wake Forest University School of Medicine. Dr. Feldman, who is leading i3 Health’s CME/NCPD/CPE activity Patient Point of View: PDE4 Inhibitors for the Treatment of Adult Plaque Psoriasis, dives into the latest breakthroughs in plaque psoriasis research and shares his expert insights on how these advancements are shaping patient care.

Don’t miss this opportunity to expand your knowledge and improve your practice! After listening, be sure to complete the full activity to deepen your understanding and apply what you’ve learned.

Click the link below to access the full CME/NCPD/CPE activity!

Link to the Activity: https://bit.ly/4hW9ozG

In this episode, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts General Hospital, discusses the latest advancements in early diagnosis and treatment of amyotrophic lateral sclerosis (ALS), a progressive neurological disorder that leads to motor neuron degeneration and muscle atrophy.

Following the interview, listeners can participate in an accredited activity titled Getting Ahead of the ALS Curve Through Early Detection and Intervention: Module 2 – Disease-Modifying Therapies for ALS: Weighing the Options. This activity explores the latest data on FDA-approved and emerging disease-modifying therapies, offering strategies to optimize patient outcomes. Tune in to gain expert insights from Dr. Paganoni and enhance your clinical knowledge while earning continuing education credits.

Click here to claim your credit: https://bit.ly/46cNBPO

In this episode, we explore amyotrophic lateral sclerosis (ALS) with Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts General Hospital, who shares insights on early detection and emerging treatments for this progressive neurological disorder.

Following the interview, listeners can participate in an accredited activity titled Getting Ahead of the ALS Curve Through Early Detection and Intervention: Module 1 – Enabling Earlier Detection of ALS, which focuses on strategies for enabling earlier ALS detection to improve patient outcomes. Tune in to gain valuable knowledge from Dr. Paganoni and take the next step in advancing your clinical expertise in ALS care while earning continuing education credits.

Click here to claim your credit: https://bit.ly/3XwSm4A

March marks Multiple Myeloma Awareness Month, a crucial time to highlight advances in the treatment of this complex blood cancer. Multiple myeloma is the leading indication of autologous hematopoietic stem cell transplantation (ASCT) in hematologic malignancies, with high-dose therapy followed by ASCT representing a potentially curative treatment modality for eligible patients. Dr. Hamza Hashmi, Assistant Attending in the Myeloma & Cell Therapy Service at Memorial Sloan Kettering Cancer Center, is currently serving as chair of i3 Health CME/NCPD activity, Cracking the Code to Successful Stem Cell Mobilization in Multiple Myeloma. In this interview, Dr. Hashmi shares additional insights into the evolving role of transplantation in this disease and the importance of education and advocacy during Multiple Myeloma Awareness Month.

Click the link for the full activity! bit.ly/4hyVwLn

As we recognize Kidney Cancer Awareness Month this March, advancements in renal cell carcinoma (RCC) treatment continue to evolve. Recently, Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC, a Nurse Practitioner and expert in genitourinary oncology, chaired the i3 Health’s NCPD activity titled Toxicity Management and Symptom Control in Advanced RCC: Playbook Update. In this interview, she shares updates in RCC treatment, strategies for toxicity management, and the importance of patient education.

Click here for the full NCPD activity! https://i3health.com/course-information/toxicity-management-and-symptom-control-in-advanced-rcc-playbook-update

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With new advances in developing MCED testing and implementing it into practice, Dr. Vega sat down with us again to share additional insights from Module 1 of the activity, including how MCED testing is helping to address the cancer screening gap in the US and the importance of staying up to date on developments in MCED testing. Afterwards, stay tuned to hear the full activity and learn how to claim CME credit.

Click here to claim your CME credit: bit.ly/3X8apxa

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With new advances in developing MCED testing and implementing it into practice, Dr. Vega sat down with us again to share additional insights from Module 2 of the activity, including the value of MCED testing for cancer survivors and ongoing trials investigating MCEDs that he’s looking forward to seeing results of in the near future. Afterwards, stay tuned to hear the full activity and learn how to claim CME credit.

Click here to claim your CME credit: bit.ly/41rS14I

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With new advances in developing MCED testing and implementing it into practice, Dr. Vega sat down with us again to share additional insights from Module 3 of the activity, including questions he commonly gets from patients about MCED testing and advice for clinicians about employing shared decision making with patients to choose the most appropriate type of cancer screening for them. Afterwards, stay tuned to hear the full activity and learn how to claim CME credit.

Click here to claim your CME credit: bit.ly/4b9JU00

Cognitive impairment is a core feature of schizophrenia, significantly contributing to functional disability and long-term challenges. Patients often experience poor attention, disorientation, stereotyped thinking, and difficulty with abstract thought, all of which hinder daily functioning and independence.

In Module 3 of this podcast, expert Dr. Christoph U. Correll explores current and emerging treatments aimed at improving cognitive function in schizophrenia. Topics include novel pharmacologic strategies, psychosocial interventions, and lifestyle modifications designed to enhance cognitive abilities and overall patient outcomes. Stay informed on the latest research and therapeutic approaches to help optimize care for individuals with schizophrenia.

Click here to claim your FREE CME/NCPD/CPE credit:

To hear about how to incorporate the latest therapeutic advances for schizophrenia into patient-centered care, continue to Module 4:

Schizophrenia is a highly complex and multifactorial mental illness, with symptoms, presentations, and outcomes varying widely among individuals. Genetic, environmental, and personal factors all play a role in disease progression, making individualized treatment essential for optimal outcomes.

In Module 4 of this podcast, expert Dr. Christoph U. Correll discusses how evidence-based strategies, shared decision-making, and holistic recovery approaches can enhance patient care. Learn how to integrate patient experiences, caregiver collaboration, and interdisciplinary teamwork to optimize treatment and improve quality of life for individuals living with schizophrenia.

Click here to claim your FREE CME/NCPD/CPE credit: